Prof. Dr. Annette Kopp-Schneider

Prof. Dr. Annette Kopp-Schneider

Prof. Dr. Annette Kopp-Schneider

Position:

Head of Division

Phone:

+49 6221 42 2391

Fax:

+49 6221 42 2397

Building:

TP 4

Room:

S4.225

Background

  • Diploma in Mathematics, RWTH Aachen, Germany, 1984
  • Dr. rer. nat., Mathematics, RWTH Aachen, Germany, 1987
  • Habilitation, Medical Biometry, University Heidelberg, 1997

 

Areas of Work

  • Clinical trials for precision oncology
  • Dose response modelling
  • Biological based mechanistic modelling of cell systems

 

Selected Publications

Kopp-Schneider A, Calderazzo S, Wiesenfarth M. Power gains by using external information in clinical trials are typically not possible when requiring strict type I error control. Biom J. 2019 Jul 2. doi: 10.1002/bimj.201800395 

Calderazzo S, Tavel D, Zurich MG, Kopp-Schneider A. Model-based estimation of lowest observed effect concentration from replicate experiments to identify potential biomarkers of in vitro neurotoxicity. Arch Toxicol. 2019 Jul 19. doi: 10.1007/s00204-019-02520-8 

Maier-Hein L, Eisenmann M, …, Jannin P, Kopp-Schneider A. Why rankings of biomedical image analysis competitions should be interpreted with care. Nat Commun. 2018 Dec 6;9(1):5217. doi: 10.1038/s41467-018-07619-7
 
Kopp-Schneider A, Wiesenfarth M, Witt R, Edelmann D, Witt O, Abel U. (2019) Monitoring futility and efficacy in phase II trials with Bayesian posterior distributions-A calibration approach. Biom J. 61: 488-502. doi: 10.1002/bimj.201700209
 
Holland-Letz T, Gunkel N, Amtmann E, Kopp-Schneider A. (2018) Parametric modelling and optimal experimental designs for estimating isobolograms for drug interactions in toxicology. J Biopharmaceut Stat 28(4):763-777. doi: 10.1080/10543406.2017.1397005
 
Habermehl C, Benner A, Kopp-Schneider A. (2018) Addressing small sample size bias in multiple-biomarker trials: Inclusion of biomarker-negative patients and Firth correction. Biom J. 60(2):275-287. doi: 10.1002/bimj.201600226
 
Holland-Letz T, Kopp-Schneider A. (2018) Optimal experimental designs for estimating the drug combination index in toxicology. Computational Statistics and Data Analysis 117: 182–193. doi: 10.1016/j.csda.2017.08.006
 
Jiang X., Kopp-Schneider A. (2014) Summarizing EC50 estimates from multiple dose-response experiments: a comparison of a meta-analysis strategy to a mixed-effects model approach. Biom J. 56(3), 493-512. doi: 10.1002/bimj.201300123
 
 

to top